{"schema_version":"1","generated_at":"2026-11-02T07:59:02.362Z","data_as_of":null,"url":"https://www.findmykol.com/kol/rajesh-belani","json_url":"https://www.findmykol.com/kol/rajesh-belani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"rajesh-belani","name":"Rajesh Belani","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Vividion Therapeutics","institution_url":"https://www.findmykol.com/institution/vividion-therapeutics","city":"San Diego","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1578509113","orcid":"0009-0006-7618-8435","openalex":"A5082829008"},"summary":"Rajesh Belani is an Oncology physician affiliated with Vividion Therapeutics. OpenAlex indexes 55 publications with 768 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":55,"cited_by_count":768,"h_index":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04249947","title":"P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Poseida Therapeutics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT04249947","trial_url":"https://www.findmykol.com/trial/NCT04249947"},{"nct":"NCT03288493","title":"P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Poseida Therapeutics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT03288493","trial_url":"https://www.findmykol.com/trial/NCT03288493"}],"source":"trials"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-25-3052","status":"verified"},{"title":"TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial","year":2025,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-025-65267-0","status":"verified"},{"title":"A Phase 1 Study of P-BCMA-ALLO1, a Non-Viral, Allogeneic BCMA Directed CAR-T in Relapsed/Refractory Multiple Myeloma (RRMM): Results from Optimized Lymphodepletion Cohort (Arm C)","year":2025,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2025.01.051","status":"verified"},{"title":"835 | A MULTICENTER, OPEN‐LABEL, Ph 1 STUDY TO ASSESS THE SAFETY OF P‐CD19CD20‐ALLO1, AN ALLOGENEIC CAR‐T CELL THERAPY, IN SUBJECTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70096_835","status":"verified"},{"title":"Clinical Activity of P-BCMA-ALLO1, an Allogeneic BCMA Targeting CAR-T, in Patients with Relapsed Refractory Multiple Myeloma (RRMM) and Extramedullary Disease","year":2025,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2025.01.622","status":"verified"}],"source":"works"},"contact":{"address_1":"3075 HEALTH CENTER DR","address_2":"SUITE 102","city":"San Diego","state":"CA","zip":"921232773","phone":"858-637-7888","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1578509113","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":44}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2012-08-18","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}